Class A Common Stock |
17.1M |
$50.7M |
$2.97 |
Sep 4, 2024 |
By Decheng Anbio Limited |
|
|
Class A Common Stock |
7.61M |
$22.6M |
$2.97 |
Sep 4, 2024 |
By Decheng Capital Global Healthcare Fund (Master), LP |
|
|
Class A Common Stock |
1.28M |
$3.81M |
$2.97 |
Sep 4, 2024 |
By Decheng Capital China Life Sciences USD Fund III, L.P. |
|
|
Warrants (Right to Buy) |
438K |
|
|
Sep 3, 2024 |
By Decheng Anbio Limited |
Class A Common Stock |
|
Warrants (Right to Buy) |
175K |
|
|
Sep 3, 2024 |
By Decheng Capital Global Healthcare Fund (Master), LP |
Class A Common Stock |
|
Warrants (Right to Buy) |
32.9K |
|
|
Sep 3, 2024 |
By Decheng Capital China Life Sciences USD Fund III, L.P. |
Class A Common Stock |
|
Series A Preferred Stock |
0 |
|
|
Sep 4, 2024 |
By Decheng Anbio Limited |
Class A Common Stock |
|
Series A Preferred Stock |
0 |
|
|
Sep 4, 2024 |
By Decheng Capital China Life Sciences USD Fund III, L.P. |
Class A Common Stock |
|
Series A Preferred Stock |
0 |
|
|
Sep 4, 2024 |
By Decheng Capital Global Healthcare Fund (Master), LP |
Class A Common Stock |
|